This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockhart, S. R.
Right arrow Articles by Diekema, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockhart, S. R.
Right arrow Articles by Diekema, D. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2009, p. 242-244, Vol. 47, No. 1
0095-1137/09/$08.00+0     doi:10.1128/JCM.01889-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Identification and Susceptibility Profile of Candida fermentati from a Worldwide Collection of Candida guilliermondii Clinical Isolates{triangledown}

Shawn R. Lockhart,* Shawn A. Messer, Michael A. Pfaller, and Daniel J. Diekema

University of Iowa, Carver College of Medicine, Iowa City, Iowa 52242

Received 30 September 2008/ Returned for modification 3 November 2008/ Accepted 17 November 2008

Candida fermentati isolates make up a small percentage of the clinical isolates of the Candida guilliermondii complex and have a global distribution pattern. With the exception that the MICs of micafungin were significantly lower, the calculated average MICs for C. fermentati were not significantly different from those for C. guilliermondii.


* Corresponding author. Present address: Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G-11, Atlanta, GA 30333. Phone: (404) 639-2569. Fax: (404) 639-3546. E-mail: gyi2{at}cdc.gov

{triangledown} Published ahead of print on 26 November 2008.


Journal of Clinical Microbiology, January 2009, p. 242-244, Vol. 47, No. 1
0095-1137/09/$08.00+0     doi:10.1128/JCM.01889-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Tendolkar, S., Pfaller, M. A. (2009). In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods. J. Clin. Microbiol. 47: 3170-3177 [Abstract] [Full Text]